Sun Pharma will commercialise and manufacture LIB Therapeutics’ once-monthly cholesterol drug outside the US and China after its EU approval
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.